Among samples from endometrial cancer patients, 66.7% were positive for COX-2 expression and 73.3% were positive for iNOS expression; the positive expression rates of COX-2 and iNOS were also significantly correlated with each other (r = 0.601, p < 0.001). The gene discussed is NOS2; the disease is endometrial cancer.